Mercado de culturas celulares automatizadas da América do Norte – Tendências do setor e previsão para 2029

Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista  Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Mercado de culturas celulares automatizadas da América do Norte – Tendências do setor e previsão para 2029

  • Healthcare
  • Publish Reports
  • Sep 2022
  • North America
  • 350 Páginas
  • Número de tabelas: 85
  • Número de figuras: 35

>Mercado de culturas celulares automatizadas da América do Norte, por produto (consumíveis, instrumentos), tipo (culturas de linhas celulares infinitas, culturas de linhas celulares finitas), aplicação (desenvolvimento de medicamentos, investigação de células estaminais, medicina regenerativa , investigação de cancro, vacinas , outros), utilizador final (Empresas de biotecnologia, organizações de investigação, institutos de investigação académica, outros) Tendências e previsões do setor para 2029.

Mercado de culturas celulares automatizadas da América do Norte

Análise e insights de mercado de culturas celulares automatizadas da América do Norte

O relatório de mercado de culturas celulares automatizadas fornece detalhes de quota de mercado, novos desenvolvimentos e análise de pipeline de produtos, impacto dos participantes do mercado doméstico e localizado, analisa oportunidades em termos de bolsas de receitas emergentes, mudanças nas regulamentações de mercado, aprovações de produtos, decisões estratégicas, lançamentos de produtos. , expansões geográficas e inovações tecnológicas no mercado. Para compreender a análise e o cenário do mercado contacte-nos para um resumo do analista, a nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir o objetivo desejado.

Mercado de culturas celulares automatizadas da América do Norte

Mercado de culturas celulares automatizadas da América do Norte

Espera-se que o mercado americano de culturas celulares automatizadas ganhe crescimento de mercado no período de previsão de 2022 a 2029. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 9,1% no período de previsão de 2022 a 2029 e deverá atingir 7.797,02 milhões de euros até 2029. O aumento da procura de tecnologia de cultura celular na produção de vacinas e a ampla aceitação de técnicas de cultura celular em diversas aplicações são os principais impulsionadores que impulsionaram a procura do mercado no período de previsão.

Métrica de relatório

Detalhes

Período de previsão

2022 a 2029

Ano base

2021

Anos históricos

2020 (personalizável para 2019 - 2014)

Unidades Quantitativas

Receita em milhões de euros, volumes em unidades, preços em euros

Segmentos cobertos

Por produto (consumíveis, instrumentos), tipo (culturas de linhas celulares infinitas, culturas de linhas celulares finitas), aplicação (desenvolvimento de medicamentos, investigação com células estaminais, medicina regenerativa , investigação do cancro, vacinas , outros), utilizador final ( empresas de biotecnologia, organizações de investigação, Institutos de Investigação Académica, Outros).

Países abrangidos

EUA, Canadá, México

Participantes do mercado abrangidos

Lonza, Merck KGaA, Thermo Fisher Scientific Inc., BD, Eppendorf AG e outros

Definição do mercado de culturas celulares automatizadas da América do Norte

Automated cell culture systems are instruments that mechanically carries out the steps involved in growing and maintaining a cell culture. Useful in any lab that works with cell biology, cell signaling, protein expression, or drug discovery, an automated cell culture system helps to grow cell cultures while saving labor time and reducing errors. Automated cell culture systems can be capable of diluting samples, growing cultures in liquid with constant swirling, plating cultures, or placing cultures in wells. Increase in demand for 3D cell cultures, increasing collaboration among market players, and increasing outsourcing facilities are expected to provide a lucrative growth opportunity for the market. However, high cost of automated cell culture systems, and limitations associated with automated cell cultures are the factors expected to restraint the market growth in the forecast period.

North America Automated Cell Cultures Market Dynamics

This section deals with understanding the market drivers, opportunity, restraint, and challenge. All of this is discussed in detail below:

  • Drivers

Increasing Demand for Cell Culture Technology in Vaccine Production

Cell culture is an essential tool for molecular and cellular biology research. Today, most biotechnology products primarily rely on mass culturing cell lines. Cell cultures have applications in diverse areas and serve as a model system for numerous research efforts.

An increase in funding from the government for cell-based research is significantly triggering the market's growth. In addition, cell culture techniques are widely being used as an alternative to current egg-based strategies for developing cell-based vaccines. Cell culture has potential applications in developing viral vaccines with increased communicable diseases and pandemic risk. Thus, cell culture technology is being extensively used in developing U.S. licensed vaccines such as vaccines against rubella, smallpox, chickenpox, hepatitis, rotavirus, and polio.

Technological Advancements in Cell Culture Technology Systems

As the demand for advanced cell culture technologies in vaccine production, cancer research, and virology, among others, is increasing, certain technological developments are taking place in automated cell culture.

Thus, market players operating in the market adopt various technological developments in cell culture equipment to boost their business in various dimensions and lead to market growth. This factor could drive the North America automated cell cultures market growth.

  • Restraint

High Cost of Automated Cell Culture Systems

The cost of the product is the major setback for the market as it is expected to decrease the demand due to high cost. In the case of automated cell culture systems, the price is also high, and below the given instance will showcase the product's price.

The instruments and consumables-related products such as cell counters, reagents, buffers, and others have high prices, which shows that the cost of automated cell cultures is the primary factor expected to restrain the North America automated cell cultures market in the forecasted period.

  • Opportunity

New Product Launches and Technology Developments

Pharmaceutical and biotechnology-driven companies are working towards developing and launching new products and technologies for automated cell culture advancement and making the treatment and diagnosis methods more reachable. This has also increased the demand for an automated cell culture market for 3D cell cultures. The development of new bioreactors, platforms, softwares has led to an advancement in the automated cell culture market and its growth.

The new products and technologies launched and worked upon create good opportunities for the North America automated cell cultures market. The new platforms with advanced technologies act as a footstep closer to the advancement of the market.

  • Challenge

Development and Maintenance of Expertise            

Recruitment and retention of trained and qualified staff, staff development, capital budgets for equipment purchase, operating budget management, facility infrastructure, and change management all require proper attention for the growth and success of any market. Failure to meet needs in any of these areas can lead to a serious weakness that, if uncorrected, may compromise the credibility of a laboratory and create a situation that will be difficult to correct in the short term.

Testing and maintaining the level of expertise in testing laboratories is a tough task, and it needs high experience, which sometimes is not accessible, which causes the development process for a particular company to hinder. Thus it is anticipated to challenge the North America automated cell cultures market growth in the forecasted period.

Recent Developments

  • In August 2021, Advanced Instruments, a leading manufacturer of analytical instruments and services for bioprocessing, announced the execution of a definitive agreement to acquire Solentim, a trusted North America leader of solutions for the isolation and characterization of high-value single-cell clones in cell line development (CLD) applications. The acquisition expands both companies' positions in the bioprocess workflows for advanced therapies
  • In July 2021, BD has launched bdbiosciences.com, an updated digital marketplace for flow cytometry. The new website provides an enhanced online purchasing experience for flow cytometry users and their procurement teams

North America Automated Cell Cultures Market Scope

O mercado de culturas celulares automatizadas da América do Norte está segmentado em Produto, Tipo, Aplicação e Utilizador Final. O crescimento entre segmentos ajuda-o a analisar os nichos de crescimento e as estratégias para abordar o mercado e determinar as suas principais áreas de aplicação e a diferença nos seus mercados-alvo.

Mercado de culturas celulares automatizadas da América do Norte, por produto

  • Consumíveis
  • Instrumentos

Com base no produto, o mercado americano de culturas celulares automatizadas está segmentado em consumíveis e instrumentos

Mercado de culturas celulares automatizadas da América do Norte, por tipo

  • Culturas de linhagem celular infinita
  • Culturas de linhagens celulares finitas

Com base no tipo, o mercado de culturas celulares automatizadas da América do Norte está segmentado em culturas de linhas celulares infinitas e culturas de linhas celulares finitas

Mercado de culturas celulares automatizadas da América do Norte, por aplicação

  • Desenvolvimento de medicamentos
  • Investigação com células-tronco
  • Medicina Regenerativa
  • Pesquisa sobre o cancro
  • Vacinas
  • Outro

Com base na aplicação, o mercado americano de culturas celulares automatizadas está segmentado em desenvolvimento de medicamentos, investigação de células estaminais, medicina regenerativa, investigação do cancro, vacinas e outros.

Mercado de culturas celulares automatizadas da América do Norte, por utilizador final

  • Empresas de biotecnologia
  • Organizações de investigação
  • Institutos de Investigação Académica
  • Outro

Mercado das Culturas Celulares Automatizadas

Com base no utilizador final, o mercado americano de culturas celulares automatizadas está segmentado em empresas de biotecnologia, organizações de investigação, institutos de investigação académica e outros.

Análise/perspetivas regionais do mercado de culturas celulares automatizadas da América do Norte

O mercado de culturas celulares automatizadas da América do Norte é analisado e as informações sobre o tamanho do mercado são fornecidas por produto, tipo, aplicação e utilizador final.

Os países abordados neste relatório de mercado são os EUA, o Canadá e o México.

Em 2022, prevê-se que o mercado norte-americano de culturas celulares automatizadas cresça devido ao aumento das aplicações na investigação de células estaminais, produção de vacinas, produção de medicamentos regenerativos e descoberta de medicamentos.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Dados como novas vendas, vendas de reposição, demografia do país, atos regulamentares e tarifas de importação e exportação são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas da América do Norte e os desafios enfrentados devido à concorrência grande ou escassa de marcas locais e nacionais, e o impacto dos canais de vendas, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.

Cenário competitivo e análise da quota de mercado de culturas celulares automatizadas na América do Norte

O panorama competitivo do mercado americano de culturas celulares automatizadas fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em I&D, novas iniciativas de mercado, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos, pipelines de testes de produtos, aprovações de produtos, patentes, largura e respiração do produto, domínio da aplicação, curva da linha de vida da tecnologia. Os dados fornecidos acima estão apenas relacionados com o foco da empresa no mercado norte-americano de culturas celulares automatizadas.

Os principais players do mercado norte-americano de culturas celulares automatizadas são a Lonza, Merck KGaA, Thermo Fisher Scientific Inc., BD, Eppendorf AG, Advanced Instruments, Benchmark Scientific, Inc., BioSpherix, Ltd., Biotron Healthcare, Bulldog Bio, Cell Culture Company, LLC, CellGenix GmbH, ChemoMetec, Corning Incorporated, Cytiva (subsidiária da Danahar Corporation), FUJIFILM Holdings America Corporation, Hemilton Company, Hitachi, Ltd., Kawasaki Heavy Industries, ltd., HiMedia Laboratories, NanoEntek America, Inc. , Nexcelom Bioscience LLC., PromoCell GmbH, RWD Life Science Co., LTD, Sartorius AG, Scientica Instrumentation, Inc., SHIBUYA CORPORATION, Sphere Fluidics Limited, Tecan Trading AG, Thrive Bioscience, Inc., e outros.

Metodologia de Investigação: Mercado de Culturas Celulares Automatizadas da América do Norte

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Além disso, os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise da quota de mercado da empresa, padrões de medição, América do Norte vs regional e análise da participação dos fornecedores. Solicite a chamada do analista em caso de dúvidas adicionais.


SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Índice

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 REGULATORY FRAMEWORK FOR NORTH AMERICA AUTOMATED CELL CULTURES MARKET

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING DEMAND FOR CELL CULTURE TECHNOLOGY IN VACCINE PRODUCTION

6.1.2 TECHNOLOGICAL ADVANCEMENTS IN CELL CULTURE TECHNOLOGY SYSTEMS

6.1.3 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS

6.1.4 GROWING BIOTECHNOLOGY SECTOR, ALONG WITH RISING HEALTHCARE EXPENDITURE

6.1.5 ADVANTAGES OF AUTOMATED CELL CULTURE SYSTEMS OVER MANUAL METHODS

6.2 RESTRAINTS

6.2.1 HIGH COST OF AUTOMATED CELL CULTURE SYSTEMS

6.2.2 LIMITATIONS ASSOCIATED WITH AUTOMATED CELL CULTURES

6.2.3 MAINTENANCE AND UPDATING OF EQUIPMENT

6.2.4 LACK OF SKILLED AND CERTIFIED PROFESSIONALS

6.3 OPPORTUNITIES

6.3.1 NEW PRODUCT LAUNCHES AND TECHNOLOGY DEVELOPMENTS

6.3.2 INCREASING COLLABORATION AMONG MARKET PLAYERS

6.3.3 INCREASING OUTSOURCING FACILITIES

6.3.4 INCREASE IN DEMAND FOR 3D CELL CULTURE

6.4 CHALLENGES

6.4.1 DEVELOPMENT AND MAINTENANCE OF EXPERTISE

6.4.2 LACK OF INFRASTRUCTURE FOR CELL-BASED RESEARCH IN EMERGING ECONOMIES

7 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT

7.1 OVERVIEW

7.2 CONSUMABLES

7.2.1 MEDIA

7.2.1.1 SERUM FREE MEDIA

7.2.1.2 CLASSICAL MEDIA & SALTS

7.2.1.3 STEM CELL CULTURE MEDIA

7.2.1.4 SPECIALTY MEDIA

7.2.2 BUFFERS AND SUPPLEMENTS

7.2.2.1 PLASMA

7.2.2.2 SERA

7.2.2.3 FETAL BOVINE SERA

7.2.2.4 ADULT BOVINE SERA

7.2.2.5 OTHERS ANIMAL SERA

7.2.3 REAGENTS

7.2.3.1 SUPPLEMENTS & GROWTH FACTORS

7.2.3.2 BUFFERS & CHEMICALS

7.2.3.3 CELL DISASSOCIATION REAGENTS

7.2.3.4 BALANCED SALT SOLUTIONS

7.2.3.5 ATTACHMENT & MATRIX FACTORS

7.2.3.6 ANTIBIOTICS/ANTIMYCOTICS

7.2.3.7 CONTAMINATION DETECTION KITS

7.2.3.8 CRYOPROTECTIVE REAGENTS

7.2.3.9 OTHERS CELL CULTURE REAGENTS

7.2.4 ACCESSORIES

7.3 INSTRUMENTS

7.3.1 SUPPORTING EQUIPMENTS

7.3.1.1 CELL COUNTERS

7.3.1.2 IMAGE BASED CELL COUNTERS

7.3.1.3 FLOW CYTOMETERS

7.3.1.4 COULTER COUNTERS

7.3.1.5 CELL EXPANSION

7.3.1.6 LIQUID HANDLERS

7.3.1.7 OTHERS

7.3.2 BIOREACTORS

7.3.2.1 SINGLE USE BIOREACTORS

7.3.2.2 CONVENTIONAL BIOREACTORS

7.3.2.3 OTHERS

7.3.3 STORAGE EQUIPMENTS

7.3.3.1 REFRIGERATORS & FREEZERS

7.3.3.2 CRYOSTORAGE SYSTEMS

7.3.3.3 OTHERS

8 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY TYPE

8.1 OVERVIEW

8.2 INFINITE CELL LINE CULTURES

8.3 FINITE CELL LINE CULTURES

9 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 DRUG DEVELOPMENT

9.3 STEM CELL RESEARCH

9.3.1 EMBRYONIC STEM CELLS

9.3.2 TISSUE-SPECIFIC STEM CELLS

9.3.3 MESENCHYMAL STEM CELLS

9.3.4 INDUCED PLURIPOTENT STEM CELLS

9.4 REGENERATIVE MEDICINE

9.4.1 STEM CELL THERAPY

9.4.2 PLATELET-RICH PLASMA THERAPY (OR PRP INJECTIONS)

9.4.3 TISSUE ENGINEERING

9.4.4 AMNIOTIC-MEMBRANE DERIVED STEM CELLS

9.5 CANCER RESEARCH

9.6 VACCINES

9.7 OTHERS

10 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY END USER

10.1 OVERVIEW

10.2 BIOTECH COMPANIES

10.3 RESEARCH ORGANIZATIONS

10.4 ACADEMIC RESEARCH INSTITUTES

10.5 OTHERS

11 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY REGION

11.1 NORTH AMERICA

11.1.1 U.S.

11.1.2 CANADA

11.1.3 MEXICO

12 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

13 COMPANY PROFILE

13.1 LONZA

13.1.1 COMPANY SNAPSHOT

13.1.2 REVENUE ANALYSIS

13.1.3 COMPANY SHARE ANALYSIS

13.1.4 PRODUCT PORTFOLIO

13.1.5 RECENT DEVELOPMENTS

13.1.6 SWOT ANALYSIS

13.2 MERCK KGAA

13.2.1 COMPANY SNAPSHOT

13.2.2 RECENT FINANCIALS

13.2.3 COMPANY SHARE ANALYSIS

13.2.4 PRODUCT PORTFOLIO

13.2.5 RECENT DEVELOPMENTS

13.2.6 SWOT ANALYSIS

13.3 THERMO FISHER SCIENTIFIC INC.

13.3.1 COMPANY SNAPSHOT

13.3.2 RECENT FINANCIALS

13.3.3 COMPANY SHARE ANALYSIS

13.3.4 PRODUCT PORTFOLIO

13.3.5 RECENT DEVELOPMENTS

13.3.6 SWOT ANALYSIS

13.4 BD

13.4.1 COMPANY SNAPSHOT

13.4.2 RECENT FINANCIALS

13.4.3 COMPANY SHARE ANALYSIS

13.4.4 PRODUCT PORTFOLIO

13.4.5 RECENT DEVELOPMENTS

13.4.6 SWOT ANALYSIS

13.5 EPPENDORF AG

13.5.1 COMPANY SNAPSHOT

13.5.2 REVENUE ANALYSIS

13.5.3 COMPANY SHARE ANALYSIS

13.5.4 PRODUCT PORTFOLIO

13.5.5 RECENT DEVELOPMENTS

13.5.6 SWOT ANALYSIS

13.6 ADVANCED INSTRUMENTS

13.6.1 COMPANY SNAPSHOT

13.6.2 PRODUCT PORTFOLIO

13.6.3 RECENT DEVELOPMENTS

13.7 BENCHMARK SCIENTIFIC INC.

13.7.1 COMPANY SNAPSHOT

13.7.2 PRODUCT PORTFOLIO

13.7.3 RECENT DEVELOPMENTS

13.8 BIOSPHERIX LTD.

13.8.1 COMPANY SNAPSHOT

13.8.2 PRODUCT PORTFOLIO

13.8.3 RECENT DEVELOPMENTS

13.9 BIOTRON HEALTHCARE

13.9.1 COMPANY SNAPSHOT

13.9.2 PRODUCT PORTFOLIO

13.9.3 RECENT DEVELOPMENTS

13.1 BULLDOG-BIO, INC.

13.10.1 COMPANY SNAPSHOT

13.10.2 PRODUCT PORTFOLIO

13.11 CELL CULTURE COMPANY, LLC

13.11.1 COMPANY SNAPSHOT

13.11.2 PRODUCT PORTFOLIO

13.11.3 RECENT DEVELOPMENT

13.12 CELLGENIX GMBH

13.12.1 COMPANY SNAPSHOT

13.12.2 PRODUCT PORTFOLIO

13.12.3 RECENT DEVELOPMENTS

13.13 CHEMOMETEC

13.13.1 COMPANY SNAPSHOT

13.13.2 REVENUE ANALYSIS

13.13.3 PRODUCT PORTFOLIO

13.13.4 RECENT DEVELOPMENT

13.14 CORNING INCORPORATED

13.14.1 COMPANY SNAPSHOT

13.14.2 RECENT FINANCIALS

13.14.3 PRODUCT PORTFOLIO

13.14.4 RECENT DEVELOPMENTS

13.15 CYTIVA (SUBSIDIARY OF DANAHER CORPORATION)

13.15.1 COMPANY SNAPSHOT

13.15.2 REVENUE ANALYSIS

13.15.3 PRODUCT PORTFOLIO

13.15.4 RECENT DEVELOPMENTS

13.16 FUJIFILM HOLDINGS AMERICA CORPORATION

13.16.1 COMPANY SNAPSHOT

13.16.2 REVENUE ANALYSIS

13.16.3 PRODUCT PORTFOLIO

13.16.4 RECENT DEVELOPMENTS

13.17 HAMILTON COMPANY

13.17.1 COMPANY SNAPSHOT

13.17.2 PRODUCT PORTFOLIO

13.17.3 RECENT DEVELOPMENTS

13.18 HITACHI, LTD.

13.18.1 COMPANY SNAPSHOT

13.18.2 REVENUE ANALYSIS

13.18.3 PRODUCT PORTFOLIO

13.18.4 RECENT DEVELOPMENTS

13.19 KAWASAKI HEAVY INDUSTRIES, LTD.

13.19.1 COMPANY SNAPSHOT

13.19.2 REVENUE ANALYSIS

13.19.3 PRODUCT PORTFOLIO

13.19.4 RECENT DEVELOPMENTS

13.2 HIMEDIA LABORATORIES

13.20.1 COMPANY SNAPSHOT

13.20.2 PRODUCT PORTFOLIO

13.20.3 RECENT DEVELOPMENTS

13.21 NANOENTEK AMERICA INC. (A SUBSIDIARY OF NANOENTEK)

13.21.1 COMPANY SNAPSHOT

13.21.2 PRODUCT PORTFOLIO

13.21.3 RECENT DEVELOPMENTS

13.22 NEXCELOM BIOSCIENCE LLC.

13.22.1 COMPANY SNAPSHOT

13.22.2 PRODUCT PORTFOLIO

13.22.3 RECENT DEVELOPMENTS

13.23 PROMOCELL GMBH

13.23.1 COMPANY SNAPSHOT

13.23.2 PRODUCT PORTFOLIO

13.23.3 RECENT DEVELOPMENTS

13.24 RWD LIFE SCIENCE CO LTD.

13.24.1 COMPANY SNAPSHOT

13.24.2 PRODUCT PORTFOLIO

13.24.3 RECENT DEVELOPMENTS

13.25 SARTORIUS AG

13.25.1 COMPANY SNAPSHOT

13.25.2 REVENUE ANALYSIS

13.25.3 PRODUCT PORTFOLIO

13.25.4 RECENT DEVELOPMENTS

13.26 SCIENTICA INSTRUMENTATION, INC.

13.26.1 COMPANY SNAPSHOT

13.26.2 PRODUCT PORTFOLIO

13.26.3 RECENT DEVELOPMENTS

13.27 SHIBUYA CORPORATION

13.27.1 COMPANY SNAPSHOT

13.27.2 RECENT FINANCIALS

13.27.3 PRODUCT PORTFOLIO

13.27.4 RECENT DEVELOPMENTS

13.28 SPHERE FLUIDICS LIMITED

13.28.1 COMPANY SNAPSHOT

13.28.2 PRODUCT PORTFOLIO

13.28.3 RECENT DEVELOPMENTS

13.29 TECAN TRADING AG

13.29.1 COMPANY SNAPSHOT

13.29.2 RECENT FINANCIALS

13.29.3 PRODUCT PORTFOLIO

13.29.4 RECENT DEVELOPMENT

13.3 THRIVE BIOSCIENCE, INC.

13.30.1 COMPANY SNAPSHOT

13.30.2 PRODUCT PORTFOLIO

13.30.3 RECENT DEVELOPMENTS

14 QUESTIONNAIRE

15 RELATED REPORTS

Lista de Tabela

TABLE 1 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 2 NORTH AMERICA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 3 NORTH AMERICA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 4 NORTH AMERICA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 5 NORTH AMERICA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 6 NORTH AMERICA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCTS, 2020-2029 (EURO MILLION)

TABLE 7 NORTH AMERICA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 8 NORTH AMERICA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 9 NORTH AMERICA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 10 NORTH AMERICA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 11 NORTH AMERICA STORAGE EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 12 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 13 NORTH AMERICA INFINITE CELL LINE CULTURES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 14 NORTH AMERICA FINITE CELL LINE CULTURES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 15 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 16 NORTH AMERICA DRUG DEVELOPMENT IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 17 NORTH AMERICA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 18 NORTH AMERICA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 19 NORTH AMERICA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 20 NORTH AMERICA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 21 NORTH AMERICA CANCER RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 22 NORTH AMERICA VACCINES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 23 NORTH AMERICA OTHERS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 24 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 25 NORTH AMERICA BIOTECH COMPANIES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 26 NORTH AMERICA RESEARCH ORGANIZATIONS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 27 NORTH AMERICA ACADEMIC RESEARCH INSTITUTES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 28 NORTH AMERICA OTHERS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)

TABLE 29 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY COUNTRY, 2020-2029 (EURO MILLION)

TABLE 30 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 31 NORTH AMERICA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 32 NORTH AMERICA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 33 NORTH AMERICA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 34 NORTH AMERICA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 35 NORTH AMERICA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 36 NORTH AMERICA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 37 NORTH AMERICA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 38 NORTH AMERICA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 39 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 40 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 41 NORTH AMERICA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 42 NORTH AMERICA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 43 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 44 U.S. AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 45 U.S. CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 46 U.S. MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 47 U.S. BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 48 U.S. REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 49 U.S. INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 50 U.S. SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 51 U.S. BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 52 U.S. STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 53 U.S. AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 54 U.S. AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 55 U.S. STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 56 U.S. REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 57 U.S. AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 58 CANADA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 59 CANADA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 60 CANADA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 61 CANADA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 62 CANADA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 63 CANADA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 64 CANADA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 65 CANADA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 66 CANADA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 67 CANADA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 68 CANADA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 69 CANADA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 70 CANADA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 71 CANADA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

TABLE 72 MEXICO AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 73 MEXICO CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 74 MEXICO MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 75 MEXICO BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 76 MEXICO REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 77 MEXICO INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 78 MEXICO SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 79 MEXICO BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 80 MEXICO STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)

TABLE 81 MEXICO AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)

TABLE 82 MEXICO AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 83 MEXICO STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 84 MEXICO REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)

TABLE 85 MEXICO AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)

Lista de Figura

FIGURE 1 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: SEGMENTATION

FIGURE 11 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS AND THE GROWING BIOTECHNOLOGY SECTOR ARE EXPECTED TO DRIVE THE NORTH AMERICA AUTOMATED CELL CULTURES MARKET IN THE FORECAST PERIOD

FIGURE 12 CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA AUTOMATED CELL CULTURES MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA AUTOMATED CELL CULTURES MARKET

FIGURE 14 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2021

FIGURE 15 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2022-2029 (EURO MILLION)

FIGURE 16 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, CAGR (2022-2029)

FIGURE 17 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 18 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY TYPE, 2021

FIGURE 19 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY TYPE, 2022-2029 (EURO MILLION)

FIGURE 20 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 21 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY TYPE, LIFELINE CURVE

FIGURE 22 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2021

FIGURE 23 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2022-2029 (EURO MILLION)

FIGURE 24 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 25 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 26 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY END USER, 2021

FIGURE 27 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY END USER, 2022-2029 (EURO MILLION)

FIGURE 28 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY END USER, CAGR (2022-2029)

FIGURE 29 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY END USER, LIFELINE CURVE

FIGURE 30 NORTH AMERICA AUTOMATED CELL CULTURES MARKET : SNAPSHOT (2021)

FIGURE 31 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021)

FIGURE 32 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2022 & 2029)

FIGURE 33 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021 & 2029)

FIGURE 34 NORTH AMERICA AUTOMATED CELL CULTURES MARKET : BY PRODUCT (2022-2029)

FIGURE 35 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: COMPANY SHARE 2021 (%)

View Detailed Information Right Arrow

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

The market segments covered By Product, Type, Application, and End User.
The countries data covered in the report are the U.S., Canada, and Mexico
In 2022, The North America automated cell cultures market is expected to grow due to increasing applications in stem cell research, vaccine production, regenerative medicines production, and drug discovery.
The player's dominating the market are Lonza, Merck KGaA, Thermo Fisher Scientific Inc., BD, Eppendorf AG, and Others